AGEMICA LTD
Significant control: Yasaman Kalantarmotamedi (25–50%), Prof Ronjon Nag (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Agemica Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Agemica Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
AGEMICA LTD is an active (proposal to strike off) private limited company (company number 14790161) incorporated on 10 April 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2025, showing net assets of −£220, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 102% on the prior period (£9,955).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Dr Yasaman Kalantarmotamedi
- owns 25–50% of shares
- holds 25–50% of voting rights
- Prof Ronjon Nag
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 10 April 20233 yrs ago
- Next accounts due
- 30 January 2027in 98 days
- Confirmation statement due
- 24 April 2027in 182 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | −£220 | — | — | £1,601 | — | — | 1 |
| 30 April 2024 | £9,955 | — | — | £2,202 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-220 at 30 April 2025
- Net assets down 25% or more on the prior period-102.2% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.09
- Incorporated two to five years agoIncorporated 10 April 2023
- Register status is not ActiveActive - Proposal to Strike off
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 182 days
- Next accounts duein 98 days
- Accounts period endNet liabilities £220 · micro accounts
- Accounts period endNet assets £9,955 · micro accounts
- Incorporated
Similar companies in London
- EPICUE LTDLondon · inc. Apr 2023
- INB CONSULTING LTDLondon · inc. Apr 2023
- PLF PHARMACEUTICALS LIMITEDLondon · inc. Apr 2023
- PUBLIC GOOD PHARMA LIMITEDCovent Garden · inc. Mar 2023
- SYNTHETIC VACCINES HOLDING LTDLondon · inc. Mar 2023
- QUANTIFIED IMAGING LIMITEDLondon · inc. Mar 2023
All companies incorporated on 10 April 2023 · in Apr 2023.
Reminders for AGEMICA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.